Framingham Risk Score Calculator

The Framingham Risk Score is derived from decades of longitudinal data collected from residents of Framingham, Massachusetts, beginning in 1948. The study tracked thousands of participants over time, identifying key modifiable and non-modifiable risk factors for coronary heart disease. The resulting point-scoring algorithm assigns weighted values to each risk factor based on its independent contribution to 10-year cardiovascular event rates. Because cardiovascular risk differs significantly between men and women — particularly before and after menopause — the Framingham model uses entirely separate point tables for each sex.

The formula integrates six key risk factors: age, total cholesterol, HDL cholesterol, systolic blood pressure (with a distinction for treated vs. untreated hypertension), current smoking status, and diabetes status. Each factor contributes a positive or negative integer point value. The sum of all points is then looked up in a sex-specific risk table to derive the estimated 10-year cardiovascular disease (CVD) risk percentage. For example, a man with 9 total points has an estimated 22% 10-year CVD risk, while a woman with 9 points has an estimated 9% risk — illustrating the sex-based differences in baseline risk.

Risk categories derived from the score are: Low risk (<10%), Intermediate risk (10–20%), and High risk (>20%). These categories directly inform clinical decisions: patients in the low-risk group typically require only lifestyle counseling, intermediate-risk patients may benefit from statin therapy or more intensive monitoring, and high-risk patients generally warrant immediate pharmacological intervention. The score is also used in shared decision-making conversations, helping patients understand their absolute risk in concrete percentage terms rather than abstract relative risk comparisons.

The Framingham Risk Score, while foundational and extensively validated, carries several important limitations that clinicians should recognize. First, it was developed primarily in a white, middle-class New England population and may overestimate or underestimate risk in other ethnic groups — for example, it tends to underestimate risk in South Asian populations and overestimate it in some Hispanic subgroups. For this reason, tools like the ACC/AHA Pooled Cohort Equations (PCE) are often preferred in contemporary U.S. practice guidelines as they include more diverse populations. Second, the score does not incorporate several emerging risk factors such as C-reactive protein (CRP), coronary artery calcium (CAC) score, family history of premature CVD, chronic kidney disease, inflammatory conditions (e.g., rheumatoid arthritis, HIV), or socioeconomic factors. Third, the model applies only to patients aged 30–74 years in most validated versions; risk estimates outside this range may be unreliable. Fourth, the score estimates the probability of any cardiovascular event and should not be used as the sole determinant of treatment — clinical judgment, patient preferences, and additional testing (e.g., carotid IMT, ankle-brachial index) should complement the score. Finally, this calculator is intended for educational and reference purposes only and does not constitute medical advice.